ArticleVeterinary world2026
Article in Veterinary world, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Probiogenomics as a Computational Biotechnology Framework: Safety-Gated Genome Analytics for Candidate Probiotic Prioritization and Validation.Computational and structural biotechnology journal · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aim: The global restriction on antibiotic growth promoters (AGPs) in poultry production due to antimicrobial resistance concerns has accelerated the search for effective, sustainable alternatives. Probiotics derived from agricultural by-products offer a promising strategy to enhance gut health and productivity while reducing environmental waste. Coconut-waste, including coconut water and pulp, is rich in fermentable substrates that support the growth of lactic acid bacteria (LAB) and the production of functional metabolites. This study aimed to perform an integrated Materials and Methods: Indigenous microorganism solutions (IMOS) were produced through anaerobic fermentation of coconut water and coconut pulp for 5, 10, 15, and 20 days using a completely randomized design with four treatments and five replicates. Physicochemical properties (pH, LAB counts), enzymatic activities (cellulase and mannanase), tolerance to simulated gastrointestinal conditions (acidic pH 2.5, bile salts at 0.3% and 0.5%, and thermal exposure at 42°C), cell surface hydrophobicity, antimicrobial activity against Results: Fermentation duration significantly influenced all evaluated parameters (p < 0.05). IMOS fermented for 15 days exhibited the lowest pH (3.19 ± 0.02), the highest LAB population (2.05 ± 0.13 × 10¹¹ CFU/mL), optimal cellulase (12.50 ± 0.15 U/mL) and mannanase activities (20.48 ± 0.13 U/mL), and the greatest cell surface hydrophobicity (95.09 ± 0.35%). LAB survival remained high under simulated gastrointestinal stress, reaching 80.23 ± 4.12% at pH 2.5 (6 h), 71.45 ± 0.56% in 0.5% bile salts, and 8.09 ± 0.35 × 10¹¹ CFU/mL at 42°C. Antimicrobial assays demonstrated complete inhibition of Conclusion: Coconut waste-derived IMOS demonstrates strong in vitro probiotic and synbiotic characteristics and represents a low-cost, environmentally sustainable functional feed additive for poultry. Fermentation for 15 days yielded optimal functional properties. Further in vivo validation is warranted to confirm efficacy under practical production conditions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.